PROCTER & GAMBLE HEALTH | SUPRIYA LIFESCIENCE | PROCTER & GAMBLE HEALTH/ SUPRIYA LIFESCIENCE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 27.4 | 126.1% | View Chart |
P/BV | x | 10.6 | 4.7 | 223.4% | View Chart |
Dividend Yield | % | 2.0 | 0.1 | 1,375.9% |
PROCTER & GAMBLE HEALTH SUPRIYA LIFESCIENCE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
SUPRIYA LIFESCIENCE Mar-23 |
PROCTER & GAMBLE HEALTH/ SUPRIYA LIFESCIENCE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 515 | 1,041.2% | |
Low | Rs | 3,883 | 170 | 2,283.4% | |
Sales per share (Unadj.) | Rs | 740.7 | 50.4 | 1,470.5% | |
Earnings per share (Unadj.) | Rs | 138.2 | 11.2 | 1,238.1% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 12.6 | 1,228.2% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0.60 | 15,833.3% | |
Avg Dividend yield | % | 2.1 | 0.2 | 1,173.4% | |
Book value per share (Unadj.) | Rs | 447.6 | 86.9 | 515.0% | |
Shares outstanding (eoy) | m | 16.60 | 80.48 | 20.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 6.8 | 91.8% | |
Avg P/E ratio | x | 33.5 | 30.7 | 109.0% | |
P/CF ratio (eoy) | x | 29.8 | 27.1 | 109.9% | |
Price / Book Value ratio | x | 10.3 | 3.9 | 262.0% | |
Dividend payout | % | 68.7 | 5.4 | 1,278.8% | |
Avg Mkt Cap | Rs m | 76,761 | 27,581 | 278.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 556 | 370.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 4,054 | 303.3% | |
Other income | Rs m | 184 | 100 | 184.1% | |
Total revenues | Rs m | 12,480 | 4,154 | 300.4% | |
Gross profit | Rs m | 3,247 | 1,284 | 252.8% | |
Depreciation | Rs m | 281 | 118 | 237.8% | |
Interest | Rs m | 8 | 31 | 24.6% | |
Profit before tax | Rs m | 3,142 | 1,235 | 254.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 336 | 251.9% | |
Profit after tax | Rs m | 2,295 | 899 | 255.4% | |
Gross profit margin | % | 26.4 | 31.7 | 83.3% | |
Effective tax rate | % | 27.0 | 27.2 | 99.0% | |
Net profit margin | % | 18.7 | 22.2 | 84.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 4,649 | 251.9% | |
Current liabilities | Rs m | 6,791 | 958 | 709.0% | |
Net working cap to sales | % | 40.0 | 91.0 | 44.0% | |
Current ratio | x | 1.7 | 4.9 | 35.5% | |
Inventory Days | Days | 263 | 24 | 1,113.0% | |
Debtors Days | Days | 343 | 76 | 450.6% | |
Net fixed assets | Rs m | 10,617 | 3,554 | 298.7% | |
Share capital | Rs m | 166 | 161 | 103.1% | |
"Free" reserves | Rs m | 7,265 | 6,834 | 106.3% | |
Net worth | Rs m | 7,431 | 6,995 | 106.2% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 8,203 | 272.2% | |
Interest coverage | x | 409.1 | 40.4 | 1,011.8% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.5 | 111.4% | |
Return on assets | % | 10.3 | 11.3 | 91.0% | |
Return on equity | % | 30.9 | 12.8 | 240.4% | |
Return on capital | % | 42.4 | 18.1 | 234.2% | |
Exports to sales | % | 0 | 88.8 | 0.0% | |
Imports to sales | % | 13.1 | 23.5 | 55.5% | |
Exports (fob) | Rs m | NA | 3,598 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 953 | 168.4% | |
Fx inflow | Rs m | 1,465 | 3,598 | 40.7% | |
Fx outflow | Rs m | 1,605 | 953 | 168.4% | |
Net fx | Rs m | -140 | 2,645 | -5.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 662 | 356.6% | |
From Investments | Rs m | -215 | -1,331 | 16.1% | |
From Financial Activity | Rs m | -985 | -34 | 2,924.6% | |
Net Cashflow | Rs m | 1,160 | -703 | -165.0% |
Indian Promoters | % | 0.0 | 68.3 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 10.7 | 187.3% | |
FIIs | % | 6.2 | 5.4 | 116.2% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 31.7 | 152.0% | |
Shareholders | 56,778 | 87,980 | 64.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | SUPRIYA LIFESCIENCE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -0.67% | 0.45% |
1-Month | -1.15% | 23.23% | 2.55% |
1-Year | 0.73% | 89.89% | 56.14% |
3-Year CAGR | -8.76% | 1.70% | 15.22% |
5-Year CAGR | 4.97% | 1.01% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the SUPRIYA LIFESCIENCE share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of SUPRIYA LIFESCIENCE the stake stands at 68.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of SUPRIYA LIFESCIENCE .
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
SUPRIYA LIFESCIENCE paid Rs 0.6, and its dividend payout ratio stood at 5.4%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of SUPRIYA LIFESCIENCE .
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.